Abstract
The Scottish Medicines Consortium advises NHS Scotland on the clinical and cost-effectiveness of new medicines. Recent process changes have given patients and clinicians a stronger voice in decisions for end of life and orphan medicines. Thematic analysis of information provided by patients and carers has improved our understanding of the key factors that are important to patients.
Original language | English |
---|---|
Publication status | Published - 10 May 2016 |
Externally published | Yes |
Event | HTAi 2016 Annual Meeting : Informing Health Care Decisions with Values and Evidence - Keio Plaza Hotel, Tokyo, Japan Duration: 10 May 2016 → 14 May 2016 http://meeting.htai.org/events/tokyo2016/event-summary-4023afce0ec04ab387500e87f0a6a42d.aspx (Conference website) |
Conference
Conference | HTAi 2016 Annual Meeting |
---|---|
Abbreviated title | HTAi 2016 |
Country/Territory | Japan |
City | Tokyo |
Period | 10/05/16 → 14/05/16 |
Internet address |